This site is intended for healthcare professionals
Drug news

FDA accepts NDA for telotristat etiprate to treat carcinoid syndrome with PDUFA target action date of November 30, 2016.-Lexicon Pharma.

Read time: 1 mins
Last updated:4th Jun 2016
Published:4th Jun 2016
Source: Pharmawand
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest